• Welcome to the Data Extraction Form for the Scoping Survey: Research Intervention "Pretreatment Activity and Rehabilitation for neoAdjuvant Gynecology  Oncology Patients"  (PARAGON)

  •  - -
  • Important info
  • If Yes, it was a Protocol Only: Complete the form as far as you can, stopping at Results because the protocol will not include those in the article.

  • If yes, do not progress.  Please contact the research team and continue to next article.  Please provide them with the author Last name and year.

  •  Forward progress on the this article should be paused. Please save this page, and go to the second to last tab and hit submit and that will ensure an email gets sent to us.  We will be notified and let you know however please reach out to us anyway at any of the following emails. Please progress to your next article.

    kutinak@duq.edu, marchetti@duq.edu, Campbellg2@duq.edu

     

  • INFORMATION:

    This is regarding the DEMOGRAPHICS data from you paper only.  Choose YES, if your article DID NOT provide totals combining all of the group means and use the table below, the total means will then be calculated for you.  

    If this was not the case, and your article provided entire combined group demographics please say no, and click the link HERE below

  • HERE.

  •  
  • WHAT(procedures): Describe each of the procedures, activities,and/or processes used in the intervention, including any enabling or support activities.

  • DOSE/DOSAGE: This compiles several factors:

    1. Length: Total Length of intervention,  The total amount of time from intitiation of intervention to its conclusion. 
    2. Duration: Duration reflects the amount of time accrued in a single exercise session and, for aerobic/endurance exercise,
      is most often characterized as minutes or hours
    3. Frequency :The number of times the intervention was delivered over the total duration of the intervention.
    4. Intensity: the amount of physical or mental work put forth by the patient during a particular movement or series of movements, exercise, or activity during a therapy session Length 
  • DOSE:

    Duration, Frequency, and Intensity

  • Mode of Delivery of Intervention

  • If your intervention was preceding not all of the below listed treatments, or was preceding just one, please leave the others blank.

  • OMIT TABLES.                                    Tables Below:

    The table below conern only the functional outcome test measures (There are examples on the last tab or in the FAQs pages). 

    Clinical significance refers to the "difference" in the measure and if it is of clinical significance to the patient, versus statistical significance. Many papers will not report this, however if we have the means, and how they changed we can determine it ourselves later.  It may be reported by MCIDs (Minimal clinically important differences) or MDCs, (minimal detectable change) and then how much above these their outcomes improved. These could be in percentages, a score, medians, T or F values, or most commonly as a Cohen's D and the paper will report it etc. Please see the last page or the FAQs sheet for further definition.  The paper may report this is a clinical significance as well, however not report a value.

    The statistical significance will be from the specific statistical tests, and those will be defined by what value the article chooses as their level of significance.  So this is typically the p < .05 or p=.002 etc. Or a Confidence Interval will be provided like 25 [12,46].  These are statisical differences

  • OMIT TABLES.              For the following tables, please choose from the following study group comparisons.

  • OMIT.                 For the following tables, please refer to the outcomes you listed on page 3 or the outcomes tab.  You can click the tab to return to that page.

  •  
  •  
  •  
  •  
  •  
  • OMIT THIS PAGE. Results II Organized by Study Design with Dynamic Response Options Based on Selections

    This is for the collection of the results and the numeric data
  • Browse Files
    Drag and drop files here
    Choose a file
    Cancelof
  • Browse Files
    Drag and drop files here
    Choose a file
    Cancelof
  • Browse Files
    Drag and drop files here
    Choose a file
    Cancelof
  • The outcomes below are selected as a few common Functional Outcome Measures used in this population, however if you have already reported for these above, you can leave them blank.

  •  Outcomes

    REMINDER!  The focus of this scoping review is to determine what changes, if any, impacted the FUNCTIONAL outcomes only which includes both patient reported (a survey) and performance based (such as 6MWT) Therefore please report only the functional The primary outcome of your article, might not be functional, but the secondary may be functional. 
    We have tried below to provide options where you can delineate whether the primary outcome was a functional outcome or not, and to limit your reporting to the functional outcomes only. 
    There are options to list the other outcomes that were included, please put the other outcomes that were not functional there but they are not used for analysis. 
    We would like to only collect the critical information about the FUNCTION OUTCOMES. 
    We have tried to compile a list  of as many functional outcomes as possible that may be used in these articles, however we may not have captured them all. 
    If there is any question, and you are not sure whether it is or not, please email me kutinak@duq.edu because it is not always obvious.

    Adherence measure

    In healthcare and medical research, adherence measures assess individuals' adherence to prescribed treatments or recommendations, aiding in monitoring and identifying factors influencing patient adherence. These may be provided in percentages, rates of drop out, days completed etc.

    Implementation Ouctomes Definitions and Understanding:

    Effectiveness (Does it work… in the real world?)

    Process of delivery (How does it work?)

    Acceptability (Will people be willing to use it?)

    Cost (How much does it cost to implement?)

    Appropriateness (Is this the right intervention?)

    Reach (How many people are exposed and benefit?)

    Intensity (What is the expected strength of the intervention?)

    Satisfaction (Are stakeholders satisfied and to what degree?)

    Sustainability (Can it be continued over time?)

     

    Effectiveness

    The PROMIS Physical Function portion is scored on a 0-point to 100-point scale, with a population mean of 50 and SD of 10.

    Intervention Componentry

    Frequency, Dosage, Intensity

    Frequency-

    How often was the intervention provide on a cyclicle basis, if it was once, then it was a singular session, however that is not typically what is ideal.  Frequency is usally 2x per week for 4 weeks. 

    Intensity

    Intensity has been referred to as the “frequency of repetitions of the desired movement”,  “amount of external work” , or “amount of time that is dedicated to practice”

    We define intensity as: the amount of physical or mental work put forth by the patient during a particular movement or series of movements, exercise, or activity during a therapy session.

    Dosage -

    How many of what type of exercise (weights, biking for time, exercise band for 2 sets of 10, etc)

    The Timed Up and Go Test (TUG) assesses mobility, balance, walking ability, and fall risk in older adults.  It is an objective measure with the patient starting seated in a chair, and they rise and walk, turn, and walk back to chair.  Certain scores on this are associated with a meaningful change.  These may be defined in the article they may not, but if you report the score, we can determine that information.

    The 6 minute walk test (6MWT) assesses distance walked over 6 minutes as a sub-maximal test of aerobic capacity/endurance.

    Functional Outcome:

    These can be measured by performance based tests, with objective measures such as walking speed and endurance and can also be patient reported measures of function found in surveys or questionnaires.  Functional outcomes measure a patient's physical, psychological, or social functioning resulting from a medical intervention. These outcomes reveal the impact on a patient's well-being and help professionals understand treatment effects on daily life.

    Health-Related Quality of Life (HRQOL): HRQOL are typically surveys with measures that encompass a broader assessment of a patient's well-being, considering physical, emotional, social, and mental aspects of life.

    Prehabiliation:

    In terms of prehabilitation, we are looking for rehabilitation, activity, exercise - monitored, or independent -, as well as other modalities provided to the patient PRIOR to their neoAdjuvant chemotherapy, primarily, however most of the literature is prior to surgery.  

    Control Group:

    A control condition serves as a reference point to measure the effects of an experimental treatment, providing a baseline for outcome assessment. Typically is the usual standard of care provided and then compared to the intervention.

    Remote support:

    Remote support involves providing healthcare services, guidance, and monitoring from a distance using telecommunication technologies. We re interested in if this was provided to determine if it should be included in our intervention to provide the patients support between visits or during their activity prior to treatment.

    Statistically significant:

    A statistically significant outcome indicates a meaningful and reliable difference or relationship between groups or variables.  This may be defined by whatever level of significance is set and then p is < or  .05, or it may be an F score, or a T score, in the outcomes table, asking which outcome were the results in favor of, there is a place to put this value.

    Clinically Significant Differences:

    Effectiveness

    The PROMIS Physical Function portion is scored on a 0-point to 100-point scale, with a population mean of 50 and SD of 10.

    Minimal Clinical Impportant Difference (MCID)

    MCID in the context of a 6-Minute Walk Test (6MWT) means "Minimal Clinically Important Difference." It signifies the slightest significant change in 6MWT distance, This aids healthcare professionals, researchers, and patients determine whether a post-intervention distance change is clinically meaningful.

    Cohen’s D ( if the paper reports an effect size, this would be helpful to jot down in the "other" section or with the outcome measure in results.  Somes this is reported as its own number, or it can be an F value.

    Cohen's d quantifies effect size (how much actualy clinical improvement or decline there was pre and post intervention that is meaningful clinically) in medical research, precisely: The standardized difference between two compared groups or conditions, helping assess clinical significance using standard deviation units. It aids in evaluating treatment effects or medical outcome differences.

    MDC (Minimal Detectable Change) - the slightest reliably detectable change in a variable with a specified confidence level. This outcome is frequently used to see if there was any significant clinical improvement that can be inferred by how well the patient did on the outcome measure or test.  

     

  • References:

    1. Meagan M. Wasfy, MD; Aaron L. Baggish, MD,." Exercise Dose in Clinical Practice". Circulation. 2016;133:2297-2313. 
    2. Gaizka Goikoetxea-Sotelo 1 , 2 , 3 , † and Hubertus J. A. van Hedel. "Defining, quantifying, and reporting intensity, dose, and dosage of neurorehabilitative interventions focusing on motor outcomes."  Front Rehabil Sci. 2023; 4: 1139251.

     

  • Should be Empty: